Price to Earning ratio Analysis of AstraZenca Pharma India Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY PE
Period Ending - Mar-25
Very Poor PE
185.91
Period Ending - Mar-24
Very Poor PE
82.48
Growth
125.39 %
Trailing Twelve Months PE
Period Ending - Mar-25
Very Poor PE
197.67
PE Analysis of AstraZenca Pharma India Ltd.
| P/E Ratio of AstraZenca Pharma India Ltd. with value of 197.67 shows that stock price is high compared to company earnings and may be overvalued. |
| PE Ratio of ASTRAZEN rose handsomely by 125.39 % this year. |
| PE Ratio with value of 185.91 was highest in Year Mar-25 in last Five Years. |
| PE Ratio with value of 80.64 was lowest in Year Mar-21 in last Five Years. |
| Latest PE Ratio with value of 185.91 is Greater than Average PE of 106.90 in last five years. |
Other PE Related Info of ASTRAZEN that may interest you.
AstraZenca Pharma India Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ASTRAZEN | 9150.50 | 9102.50 | 0.527 % | Drugs & Pharma |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Poor Value Stock | Screener |
FY - Historical Price to Earning of AstraZenca Pharma India Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| PE | 185.91 | 82.48 | 81.93 | 103.55 | 80.64 | 83.24 | 91.31 |
| Change | 125.39 % | 0.670 % | -20.87 % | 28.41 % | -3.12 % | -8.84 % | 1.98 % |
| Price | 8607.65 | 5328.45 | 3252.80 | 2551.85 | 3009.30 | 2403.85 | 1988.65 |
| Price Change | 61.54 % | 63.81 % | 27.47 % | -15.20 % | 25.19 % | 20.88 % | 114.40 % |
FY Chart of Price to Earning of AstraZenca Pharma India Ltd.
Understanding Price to Earning
Value Investing eBook
Free PDF eBook on Value Investing
Value Investing eBook
Free PDF eBook on Value Investing